sulfasalazine has been researched along with Arthritis, Juvenile Chronic in 60 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine." | 7.70 | Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. ( Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I, 2000) |
"AP is an important complaint in young adults with JIA and is associated with fatigue, female gender, methotrexate and sulfasalazine use." | 4.12 | Abdominal pain in Finnish young adults with juvenile idiopathic arthritis. ( Aalto, K; Glerup, M; Kautiainen, H; Peltoniemi, S; Rebane, K; Tuomi, AK, 2022) |
"We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine." | 3.70 | Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. ( Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I, 2000) |
" Patients were treated with a dosage of 50 mg/kg/day of SSZ (maximum 2,000 mg/day) or placebo." | 2.69 | Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. ( Dijkmans, BA; Dijkstra, PF; Fiselier, TJ; Franssen, MJ; Kuis, W; Oostveen, JC; ten Cate, R; van Ede, CF; van Luijk, WH; van Rossum, MA; van Soesbergen, RM; van Suijlekom-Smit, LW; Wulffraat, NM; Zwinderman, AH, 1998) |
"Its application for juvenile chronic arthritis (JCA) is limited so far and controversial results for the efficacy of this therapy have been published." | 2.69 | Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis. ( Dyankov, ED; Varbanova, BB, 1999) |
"Sulfasalazine was stopped in 7 patients: for toxicity in 4 and for inefficacy in 3." | 2.67 | Sulfasalazine treatment in juvenile chronic arthritis: an open study. ( Goemaere, S; Joos, R; Mielants, H; van Werveke, S; Veys, EM, 1991) |
"Juvenile idiopathic arthritis is the most frequent chronic rheumatic disease in childhood." | 2.53 | The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis. ( Horneff, G; Hügle, B, 2016) |
"Before the biologic era, treatment of juvenile idiopathic arthritis (JIA) was often highly unsatisfactory, with children forced to endure the ill effects of lifelong disease, including pain and stiffness, disability, and even increased risk of mortality." | 2.49 | Treatment of juvenile idiopathic arthritis in the biologic age. ( Cron, RQ; Stoll, ML, 2013) |
"We report on an 11-year-old girl with juvenile idiopathic arthritis, who developed Crohn's disease (CD) while taking etanercept for her arthritis." | 2.46 | Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature. ( Dick, A; Girschick, HJ; Morbach, H; Wiegering, V, 2010) |
"Sulfasalazine (SSZ) has regulatory approval for treatment of inflammatory bowel disease in children and adults, and for use as a slow acting agent in adult rheumatoid arthritis (RA)." | 2.41 | Sulfasalazine for the management of juvenile rheumatoid arthritis. ( Brooks, CD, 2001) |
"Prognostic factors in juvenile rheumatoid arthritis (JRA) include polyarticular onset, polyarticular disease course, and rheumatoid factor positivity; in the systemic onset subtype, persistence of systemic features at 6 months after onset confers a worse prognosis." | 2.41 | Current treatment of juvenile rheumatoid arthritis. ( Ilowite, NT, 2002) |
"New information on the treatment of juvenile rheumatoid arthritis emphasizes more aggressive control of arthritis, particularly the use of methotrexate, both in low- and higher-dose regimens." | 2.38 | Treatment of juvenile rheumatoid arthritis. ( Emery, HM, 1993) |
"We report a 15-year-old boy with juvenile rheumatoid arthritis who developed DIHS due to sulfasalazine, associated with reactivation of HHV-6." | 1.35 | Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation. ( Balci, DD; Dogramaci, CA; Duran, N; Peker, E, 2009) |
"Sulfasalazine (SSZ) has recently been shown to be effective for the management of juvenile rheumatoid arthritis (JRA)." | 1.31 | Sulfasalazine therapy for juvenile rheumatoid arthritis. ( Chen, CC; Chiang, BL; Lin, YT; Yang, YH, 2002) |
"Four children with chronic arthritis (3 juvenile rheumatoid arthritis and 1 juvenile ankylosing spondylitis) and poorly controlled chronic uveitis, were given sulphasalazine (SASP) therapy for a mean period of 3." | 1.30 | Sulphasalazine therapy in chronic uveitis of children with chronic arthritis. ( Hsieh, KH; Huang, JL; Hung, IJ, 1997) |
"A 12-year-old girl with juvenile rheumatoid arthritis developed fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia, which was confirmed by liver histology and bone marrow examination, 2 weeks after initiation of sulphasalazine therapy." | 1.30 | Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin. ( Chen, LC; Hsieh, KH; Hsueh, C; Huang, JL; Hung, IJ; Lee, WY, 1998) |
"Two 19 year old patients with juvenile chronic arthritis developed liver toxicity during treatment with sulphasalazine." | 1.28 | Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis. ( Caspi, D; Fuchs, D; Yaron, M, 1992) |
"In 38 children with juvenile chronic arthritis the authors tested Sulphasalazine in an open clinical trial." | 1.28 | [Sulfasalazine in the treatment of chronic juvenile arthritis]. ( Havelka, S; Hoza, J; Kadlecová, T; Nĕmcová, D, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (13.33) | 18.7374 |
1990's | 20 (33.33) | 18.2507 |
2000's | 15 (25.00) | 29.6817 |
2010's | 11 (18.33) | 24.3611 |
2020's | 6 (10.00) | 2.80 |
Authors | Studies |
---|---|
Rebane, K | 1 |
Tuomi, AK | 1 |
Kautiainen, H | 1 |
Peltoniemi, S | 1 |
Glerup, M | 1 |
Aalto, K | 3 |
Broekaert, IJ | 3 |
Klein, A | 3 |
Windschall, D | 3 |
Rogalski, B | 3 |
Weller-Heinemann, F | 3 |
Oommen, P | 3 |
Küster, M | 3 |
Foeldvari, I | 3 |
Minden, K | 3 |
Hospach, A | 3 |
Hufnagel, M | 3 |
Berger, T | 3 |
Geikowski, T | 3 |
Quietzsch, J | 3 |
Horneff, G | 4 |
Macaraeg, M | 1 |
Schulert, GS | 1 |
Sukharomana, M | 1 |
Charuvanij, S | 1 |
Tarkiainen, M | 2 |
Tynjälä, P | 2 |
Vähäsalo, P | 2 |
Kröger, L | 2 |
Lahdenne, P | 2 |
Ayaz, NA | 1 |
Karadağ, ŞG | 1 |
Koç, R | 1 |
Demirkan, FG | 1 |
Çakmak, F | 1 |
Sönmez, HE | 1 |
Marino, A | 1 |
De Souza, M | 1 |
Giani, T | 1 |
Cimaz, R | 1 |
Hissink Muller, P | 1 |
Brinkman, DMC | 1 |
Schonenberg-Meinema, D | 1 |
van den Bosch, WB | 1 |
Koopman-Keemink, Y | 2 |
Brederije, ICJ | 1 |
Bekkering, PW | 1 |
Kuijpers, TW | 2 |
Van Rossum, M | 1 |
van Suijlekom-Smit, LWA | 1 |
van den Berg, JM | 2 |
Boehringer, S | 1 |
Allaart, CF | 2 |
Ten Cate, R | 7 |
Stoll, ML | 1 |
Cron, RQ | 2 |
Lorenzo, N | 1 |
Cantera, D | 1 |
Barberá, A | 1 |
Alonso, A | 1 |
Chall, E | 1 |
Franco, L | 1 |
Ancizar, J | 1 |
Nuñez, Y | 1 |
Altruda, F | 1 |
Silengo, L | 1 |
Padrón, G | 1 |
Del Carmen Dominguez, M | 1 |
Agarwal, NN | 1 |
Patil, D | 1 |
Nagendra, S | 1 |
Jadhav, SM | 1 |
Hügle, B | 1 |
Hissink Muller, PC | 1 |
Brinkman, DM | 1 |
Schonenberg, D | 1 |
Brederije, IC | 1 |
Bekkering, WP | 1 |
van Rossum, MA | 6 |
van Suijlekom-Smit, LW | 6 |
Wiegering, V | 1 |
Morbach, H | 1 |
Dick, A | 1 |
Girschick, HJ | 1 |
Balci, DD | 1 |
Peker, E | 1 |
Duran, N | 1 |
Dogramaci, CA | 1 |
Piñana, E | 1 |
Lei, SH | 1 |
Merino, R | 1 |
Melgosa, M | 1 |
De La Vega, R | 1 |
Gonzales-Obeso, E | 1 |
Ramírez, E | 1 |
Borobia, A | 1 |
Carcas, A | 1 |
Malin, M | 1 |
Putto-Laurila, A | 1 |
Honkanen, V | 1 |
Váncsa, A | 1 |
Tóth, B | 1 |
Szekanecz, Z | 1 |
Burgos-Vargas, R | 1 |
Vázquez-Mellado, J | 1 |
Pacheco-Tena, C | 1 |
Hernández-Garduño, A | 1 |
Goycochea-Robles, MV | 1 |
Zwinderman, AH | 4 |
Boers, M | 3 |
Dijkmans, BA | 5 |
van Soesbergen, RM | 5 |
Fiselier, TJ | 5 |
Franssen, MJ | 5 |
Wulffraat, NM | 5 |
Kuis, W | 5 |
van Luijk, WH | 5 |
Oostveen, JC | 5 |
Dijkstra, PF | 2 |
SAIRANEN, E | 1 |
LAAKSONEN, AL | 1 |
Wieringa, H | 1 |
Bouayed, K | 1 |
Brik, H | 1 |
Zakari, A | 1 |
Mikou, N | 1 |
Dehbi, F | 1 |
Scherer, HU | 1 |
Burmester, GR | 1 |
Takeyama, J | 1 |
Umebayashi, H | 1 |
Inagaki, T | 1 |
Beukelman, T | 1 |
Guevara, JP | 1 |
Albert, DA | 1 |
Sherry, DD | 2 |
Burnham, JM | 1 |
Kümmerle-Deschner, J | 1 |
Dannecker, G | 1 |
Emery, HM | 1 |
Gedalia, A | 1 |
Barash, J | 1 |
Press, J | 1 |
Buskila, D | 1 |
McCarthy, C | 1 |
Coughlan, R | 1 |
Haagsma, CJ | 1 |
van Riel, PL | 1 |
Huang, JL | 3 |
Hung, IJ | 2 |
Hsieh, KH | 2 |
Gunnarsson, I | 1 |
Kanerud, L | 1 |
Pettersson, E | 1 |
Lundberg, I | 1 |
Lindblad, S | 1 |
Ringertz, B | 1 |
van Ede, CF | 1 |
Chen, LC | 2 |
Lee, WY | 1 |
Hsueh, C | 1 |
Harada, S | 1 |
Mitsunobu, F | 1 |
Kodama, F | 1 |
Hosaki, Y | 1 |
Mifune, T | 1 |
Tsugeno, H | 1 |
Okamoto, M | 1 |
Yamamura, M | 1 |
Makino, H | 1 |
Tanizaki, Y | 1 |
Sharma, S | 1 |
Lian, T | 1 |
Brittenden, J | 1 |
Pearson, S | 1 |
Emery, P | 1 |
Varbanova, BB | 1 |
Dyankov, ED | 1 |
Pepmueller, PH | 1 |
Moore, TL | 1 |
Pay, S | 1 |
Dinc, A | 1 |
Simsek, I | 1 |
Can, C | 1 |
Erdem, H | 1 |
Brooks, CD | 1 |
Ilowite, NT | 1 |
Chen, CC | 1 |
Lin, YT | 1 |
Yang, YH | 1 |
Chiang, BL | 1 |
Smith, MS | 1 |
Barker, JD | 1 |
Caspi, D | 1 |
Fuchs, D | 1 |
Yaron, M | 1 |
Rooney, M | 1 |
Suschke, HJ | 1 |
Joos, R | 1 |
Veys, EM | 1 |
Mielants, H | 1 |
van Werveke, S | 1 |
Goemaere, S | 1 |
Settas, L | 1 |
Alexiou, P | 1 |
Dimitriadis, G | 1 |
Mata-Tsi, E | 1 |
Souliou, E | 1 |
Papapanagiotou, J | 1 |
Tourkantonis, A | 1 |
Hoza, J | 2 |
Kadlecová, T | 2 |
Nĕmcová, D | 2 |
Havelka, S | 2 |
Rosenberg, AM | 1 |
Duffy, CM | 1 |
Laxer, RM | 1 |
Silverman, ED | 1 |
Ozdogan, H | 1 |
Turunç, M | 1 |
Deringöl, B | 1 |
Yurdakul, S | 1 |
Yazici, H | 1 |
Bliddal, H | 1 |
Helin, P | 1 |
Dülgeroğlu, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison of Anti-TNF Therapy Plus Methotrexate, Combination Therapy of DMARDs, and Methotrexate Alone in Very Early Polyarticular Juvenile Idiopathic Arthritis. A National Randomized Multicenter Clinical Trial.[NCT01015547] | Phase 3 | 60 participants (Actual) | Interventional | 2003-05-31 | Completed | ||
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (Pharmachild) Treated With Biologic Agents and/or Methotrexate. A PRINTO/PRES Registry[NCT01399281] | 9,000 participants (Anticipated) | Observational | 2011-12-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
13 reviews available for sulfasalazine and Arthritis, Juvenile Chronic
Article | Year |
---|---|
Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Clinical Trials as Topic; Humans; Methotrex | 2020 |
Treatment of juvenile idiopathic arthritis in the biologic age.
Topics: Abatacept; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Mo | 2013 |
The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Drug Therapy, Combination; Humans; H | 2016 |
Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Art | 2010 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl | 2006 |
Treatment of juvenile rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Erythropoietin; gamma-Globulins | 1993 |
Combination of second-line antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combinat | 1997 |
Juvenile spondyloarthropathies.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Reactive; Child; Female; Germany; | 2000 |
Sulfasalazine for the management of juvenile rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Humans; Sulfasalazine; Treatment Outcome | 2001 |
Current treatment of juvenile rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arth | 2002 |
Is there a disease-modifying drug for juvenile chronic arthritis?
Topics: Administration, Oral; Antimalarials; Arthritis, Juvenile; Child; Forecasting; Gold; Humans; Immuniza | 1992 |
Advanced drug therapy for juvenile rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Antimalarials; Arthritis, Juvenile; Child; Gold; Humans; Immunosuppressive | 1989 |
Drug therapy for juvenile arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antimet | 1989 |
14 trials available for sulfasalazine and Arthritis, Juvenile Chronic
Article | Year |
---|---|
Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Drug Therapy, Combination; Female; Hum | 2019 |
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Blood Sedimentation; Child; Child, Preschool; | 2019 |
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Drug Admin | 2017 |
Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
Topics: Adolescent; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Prescho | 2011 |
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Doub | 2002 |
Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Arthrography; Child; Child, Preschool; Female | 2003 |
Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthrography; Child; Disease Progression; Female; Humans; | 2005 |
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Drug Administration | 2007 |
Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis.
Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Male; Severity of Illness | 1993 |
Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Arthrography; Child; Child, Preschool; Diseas | 1998 |
Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Infa | 1999 |
Sulfasalazine treatment in juvenile chronic arthritis: an open study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Child, Preschool; C | 1991 |
Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Chloroquine; Female; Humans; Ma | 1991 |
Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
Topics: Adolescent; Arthritis, Juvenile; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; | 1986 |
33 other studies available for sulfasalazine and Arthritis, Juvenile Chronic
Article | Year |
---|---|
Abdominal pain in Finnish young adults with juvenile idiopathic arthritis.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheuma | 2022 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di | 2023 |
Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
Topics: Adult; Arthritis, Juvenile; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphohisti | 2023 |
Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Humans; Injections, Intra-Articular; Retrospective Studies; Sulfasalazin | 2023 |
Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumati | 2020 |
APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis
Topics: Adolescent; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Juvenile; Autoantigen | 2015 |
Bilateral hip pain in a young man? It may be worth considering juvenile-onset ankylosing spondylitis (JAS).
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Hip Joint; Humans; Male; Methylprednisolo | 2015 |
Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Drug Eruptions; Herpesvirus 6, Human; Humans; | 2009 |
DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Drug Eruptions; Drug Therapy, C | 2010 |
BTK gene mutation in two non-identical twins with X-linked agammaglobulinemia associated with polyarticular juvenile idiopathic arthritis.
Topics: Adult; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Anti-Inflammatory Agents, Non-Steroi | 2011 |
THE RESULTS OF GOLD THERAPY IN JUVENILE RHEUMATOID ARTHRITIS.
Topics: Adolescent; Arthritis; Arthritis, Juvenile; Biomedical Research; Child; Chloroquine; Drug Therapy; G | 1964 |
[Hemophagocytic syndrome occurring in polyarticular juvenile arthritis treated by salazopyrine].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Drug Combinations; Glucosamine; | 2006 |
Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematu | 2007 |
Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Canada; Child | 2007 |
Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child, Preschool; Desensitization, Immunologic; Dose-Resp | 1995 |
Sulphasalazine desensitisation in patients with arthritis.
Topics: Adult; Aged; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Desensitization, Immu | 1994 |
Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Chronic Disease; Female; Humans | 1997 |
Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Arthritis, Juvenile; Arthritis, Psoriatic; Arthrit | 1997 |
Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Female; Follow-Up Studies; Hepatic Encephalopathy; | 1998 |
Sulphasalazine in the treatment of children with chronic arthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Clinical Trials as T | 1998 |
Giant cell arteritis associated with rheumatoid arthritis monitored by magnetic resonance angiography.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Female; Giant Cell Arteritis; | 1999 |
Current treatment by United States and Canadian pediatric rheumatologists.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; C | 1999 |
Recurrent lung shadowing in adult juvenile idiopathic arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Female; Humans; Pulmonary Eosinophilia; Radiograph | 1999 |
Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Chloroquine; Humans; Immunoblastic Lymphadenopathy | 2000 |
Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Controlled Clinical Trials as To | 2001 |
Sulfasalazine therapy for juvenile rheumatoid arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Azat | 2002 |
Granulomatous ileocolitis preceded by three years of pauciarticular arthritis.
Topics: Arthritis, Juvenile; Aspirin; Child; Crohn Disease; Granuloma; Humans; Male; Prednisone; Sulfasalazi | 1978 |
Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.
Topics: Adolescent; Adult; Alkaline Phosphatase; Arthritis, Juvenile; Chemical and Drug Induced Liver Injury | 1992 |
[Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
Topics: Adolescent; Arthritis, Juvenile; Arthritis, Reactive; Child; Dose-Response Relationship, Drug; Drug | 1992 |
Effect of sulphasalazine in patients with juvenile chronic arthritis (JCA).
Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Male; Sulfasalazine | 1991 |
[Sulfasalazine in the treatment of chronic juvenile arthritis].
Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; HLA-B27 Antigen; Humans; Sulfasalazine | 1989 |
Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
Topics: Adult; Arthritis, Juvenile; Aspirin; Azathioprine; Drug Therapy, Combination; Humans; Leukopenia; Ma | 1987 |
Sulfasalazine in juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Humans; Sulfasalazine | 1988 |